1 "isolation of cDNA" 195-200, 1994
2 "anti-inflammatory or immunosuppressive" 1993
3 "World- wide distribution of a common methylenetetrahy- drofolate reductase mutation" 62 : 1258-1260, 1998
4 "Thermolabile 5,10-methylenete- trahydrofolate reductase as a cause of mild hyper- homocysteinemia" 56 : 142-150, 1995
5 "Therapeutic suppression of tissue reactivity effect of aminopterin in rheumatoid arthritis and psoriasis" 176-182, 1951
6 "Therapeutic criteria in rheumatoid arthritis" 140 : 659-662, 1949
7 "The methy- lenetetrahydrofolate reductase (MTHFR) gene maps to distal mouse chromosome 4" 7 : 864-865, 1996
8 "The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis:an open prospective study" 18 : 978-983, 1991
9 "The C677T mutation in the methy- lenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients" 44 : 2525-2530, 2001
10 "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis" 31 : 315-324, 1988
1 "isolation of cDNA" 195-200, 1994
2 "anti-inflammatory or immunosuppressive" 1993
3 "World- wide distribution of a common methylenetetrahy- drofolate reductase mutation" 62 : 1258-1260, 1998
4 "Thermolabile 5,10-methylenete- trahydrofolate reductase as a cause of mild hyper- homocysteinemia" 56 : 142-150, 1995
5 "Therapeutic suppression of tissue reactivity effect of aminopterin in rheumatoid arthritis and psoriasis" 176-182, 1951
6 "Therapeutic criteria in rheumatoid arthritis" 140 : 659-662, 1949
7 "The methy- lenetetrahydrofolate reductase (MTHFR) gene maps to distal mouse chromosome 4" 7 : 864-865, 1996
8 "The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis:an open prospective study" 18 : 978-983, 1991
9 "The C677T mutation in the methy- lenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients" 44 : 2525-2530, 2001
10 "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis" 31 : 315-324, 1988
11 "The American College of Rheumatology 1991 revised criteria for the classi- fication of global functional status in rheumatoid arthritis" 35 : 498-502, 1992
12 "Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research" 25 : 1975-1979, 1998
13 "Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensiti- vity to the low-dose methotrexate therapy in patients with rheumatoid arthritis" 11 : 593-600, 2003
14 "Polymorphisms in the methylene- tetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses" 12 : 183-190, 2002
15 "Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism" 98 : 231-234, 2001
16 "Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients" 52 : 517-523, 1997
17 "Molecular therapeutics:methotrexate and its mechanism of action" 39 : 1951-1960, 1996
18 "Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia" 34 : 525-526, 1997
19 "Methylenetetrahydrofolate reductase and neural tube defects" 348 : 58-, 1996
20 "Methotrexate: mechanism of action, pharmacokinetics, clinical indications and toxicity" 363-368, 1991
21 "Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity" 27 : 277-292, 1998
22 "Methotrexate in rheumatoid arthritis" 31 : 305-314, 1988
23 "Low-dose methotrexate in rheumatoid arthritis" 97-102, 1986
24 "Longterm methotrexate therapy in rheumatoid arthritis" 12 : 25-28, 1985
25 "Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis:84-month update" 35 : 129-137, 1992
26 "Long- term prospective trial of low-dose methotrexate in rheumatoid arthritis" 31 : 167-175, 1988
27 "Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects?: a meta-analysis" 90 : 111-115, 1997
28 "Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis" 58 : 79-84, 1999
29 "Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications" 45 : 389-394, 1999
30 "Hyperhomocysteinemia in renal transplant recipients" 2 : 308-313, 2002
31 "Hyperhomocysteinemia in chronic renal disease" 10 : 891-900, 1999
32 "Homocysteine and folate status in methotrexate- treated patients with rheumatoid arthritis" 41 : 658-665, 2002
33 "Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)." 9 : 652-656, 1998
34 "Adverse effects of low dose methotrexate therapy in rheumatoid arthritis" 20 : 1850-1856, 1993
35 "A prospective study of the long-term efficacy and toxicity of low-dose methotrexate in rheumatoid arthritis" 13 : 23-28, 1995
36 "A candidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolate reductase" 10 : 111-113, 1995
37 "5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review" 151 : 862-877, 2000
38 "5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects" 63 : 610-614, 1996